1(a). World Health Organization. (2017, March 30). "Depression: let’s talk" says WHO, as depression tops list of causes of ill health. Retrieved from
http://www.who.int/en/news-room/detail/30-03-2017--depression-let-s-talk-says-who-as-depression-tops-list-of-causes-of-ill-health
1(b). World Health Organization. (2017). Depression and Other Common Mental Disorders. Retrieved from
https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf
2. Harvard Medical School. (n.d.). National Comorbidity Survey. Retrieved from
https://www.hcp.med.harvard.edu/ncs/index.php
3(a). Trivedi MH, et al. (2006, January). Evaluation of Outcomes with Citalopram for Depression Using Measurement-Based Care in STAR*D Implications for Clinical Practice. Retrieved from
https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.163.1.28
3(b). Rush AJ, et. al. (2006, November). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Retrieved from
https://ajp.psychiatryonline.org/doi/pdf/10.1176/ajp.2006.163.11.1905
3(c). Fava M, et. al. (2006, July). A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A Star*D Report. Retrieved from
https://ajp.psychiatryonline.org/doi/pdf/10.1176/ajp.2006.163.7.1161
3(d). McGrath PJ, et al. (2006, September). Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report. Retrieved from
https://ajp.psychiatryonline.org/doi/pdf/10.1176/ajp.2006.163.9.1531
4. Levkovitz Y., et al. (2015, February 05). Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. Retrieved from
https://onlinelibrary.wiley.com/doi/abs/10.1002/wps.20199
5. Feifel D., Pappas K. (2016, October 4). Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil. Retrieved from
https://www.jove.com/pdf/53858
6. Keller D.M. (2015,0April 6). Antidepressants at Normal Doses Linked to First-Time Seizures. Retrieved from
https://www.medscape.com/viewarticle/842606
7. Brainsway Ltd. (2018). BrainsWay-D Safety Information. Retrieved from
https://www.brainsway.com/safety-information/
8. Gelenberg AJ, et al. (2010, October). Practice Guideline for the Treatment of Patients with Major Depressive Disorder Third Edition. Retrieved from
https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf